Mark Thomas Esper (born April 26, 1964)[1][2] i... - dofaq.co
Mark Thomas Esper (born April 26, 1964)[1][2] i...
wikipedia - 22 Dec 2020
Mark Thomas Esper (born April 26, 1964)[1][2] is a U.S. politician and businessman who served as the 27th United States secretary of defense from July 2019 to November 2020. He was a defense contractor lobbyist before joining the Donald Trump administration.
BioNTech gets US agency notice over default on COVID vaccine royalties
Reuters - 25 Mar 2024
BioNTech gets US agency notice over default on COVID vaccine royalties ...
BioNTech hit with 'notice of default' in COVID royalty dispute
FiercePharma - 25 Mar 2024
BioNTech hit with 'notice of default' in COVID royalty dispute ...
C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More
BioSpace - 27 Mar 2024
C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More ...
BioNTech SE ADR rises Wednesday, outperforms market
MarketWatch - 27 Mar 2024
BioNTech SE ADR rises Wednesday, outperforms market ...
Covid vaccine financial winners and losers, from Pfizer to Novavax
STAT - 25 Mar 2024
Covid vaccine financial winners and losers, from Pfizer to Novavax ...
BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties
BioSpace - 26 Mar 2024
BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties ...
BioNTech Full Year 2023 Earnings: Misses Expectations
Yahoo Finance - 24 Mar 2024
BioNTech Full Year 2023 Earnings: Misses Expectations ...
We Think You Can Look Beyond BioNTech's (NASDAQ:BNTX) Lackluster Earnings
Simply Wall St - 27 Mar 2024
We Think You Can Look Beyond BioNTech's (NASDAQ:BNTX) Lackluster Earnings ...
BioNTech pivots focus to ADCs, CAR-Ts to drive 2024 growth
BioProcess Insider - 25 Mar 2024
BioNTech pivots focus to ADCs, CAR-Ts to drive 2024 growth ...
BioNTech (NASDAQ:BNTX) Price Target Cut to $101.00 by Analysts at UBS Group
Defense World - 28 Mar 2024
BioNTech (NASDAQ:BNTX) Price Target Cut to $101.00 by Analysts at UBS Group ...
BioNTech gets notice from US agency over default on COVID vaccine royalties
Nasdaq - 25 Mar 2024
BioNTech gets notice from US agency over default on COVID vaccine royalties ...
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%
Investor's Business Daily - 20 Mar 2024
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65% ...
After earnings plunge, BioNTech pins hopes on cancer drug launches
Reuters - 20 Mar 2024
After earnings plunge, BioNTech pins hopes on cancer drug launches ...
Readout Newsletter: BioNTech, Roche, Prometheus news
STAT - 21 Mar 2024
Readout Newsletter: BioNTech, Roche, Prometheus news ...
BioNTech SE ADR falls Tuesday, underperforms market
MarketWatch - 26 Mar 2024
BioNTech SE ADR falls Tuesday, underperforms market ...
BioNTech SE ADR rises Monday, outperforms market
MarketWatch - 25 Mar 2024
BioNTech SE ADR rises Monday, outperforms market ...
BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh
MarketWatch - 20 Mar 2024
BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh ...
BioNTech SE ADR falls Friday, underperforms market
MarketWatch - 22 Mar 2024
BioNTech SE ADR falls Friday, underperforms market ...
BioNTech predicts return to revenue growth in 2025
Reuters - 09 Jan 2024
BioNTech predicts return to revenue growth in 2025 ...